LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 14.58 | 84.90 | 649 | 663 | 0.9783 | 0.9853 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 14.58 | 84.90 | 1293 | 663 | 1.9490 | 1.5046 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.29 | 84.90 | 5 | 766 | 0.0065 | -0.5901 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.29 | 84.90 | 1345 | 766 | 1.7539 | 1.3871 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.29 | 84.90 | 1166 | 766 | 1.5205 | 1.2822 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 16.29 | 84.90 | 1370 | 766 | 1.7865 | 1.4010 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.99 | 84.90 | 7 | 898 | 0.0078 | -0.5195 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.99 | 84.90 | 1377 | 898 | 1.5317 | 1.2669 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.99 | 84.90 | 1295 | 898 | 1.4405 | 1.2263 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 17.99 | 84.90 | 1460 | 898 | 1.6241 | 1.3062 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 19.69 | 84.90 | 9 | 1239 | 0.0073 | -0.4402 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 19.69 | 84.90 | 1534 | 1239 | 1.2377 | 1.1134 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 19.69 | 84.90 | 1414 | 1239 | 1.1408 | 1.0693 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 19.69 | 84.90 | 1493 | 1239 | 1.2046 | 1.0986 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.40 | 84.90 | 9 | 1454 | 0.0062 | -0.4216 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.40 | 84.90 | 1599 | 1454 | 1.0992 | 1.0467 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.40 | 84.90 | 1508 | 1454 | 1.0367 | 1.0176 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 21.40 | 84.90 | 1555 | 1454 | 1.0690 | 1.0328 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.10 | 84.90 | 15 | 1616 | 0.0093 | -0.3349 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.10 | 84.90 | 1681 | 1616 | 1.0401 | 1.0186 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.10 | 84.90 | 1594 | 1616 | 0.9863 | 0.9935 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 23.10 | 84.90 | 1642 | 1616 | 1.0160 | 1.0075 | MN20160318_Q02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.81 | 84.90 | 23 | 1769 | 0.0130 | -0.2577 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.81 | 84.90 | 1663 | 1769 | 0.9398 | 0.9719 | MN20160318_Q02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 24.81 | 84.90 | 1678 | 1769 | 0.9483 | 0.9759 | MN20160318_Q02 | L04 |